Effect of SR 27417, a novel PAF antagonist on antigen-induced hypotension in the rat.
J M Herbert, A Bernat, E Tibiriça
Index: J. Lipid Mediat. Cell Signal. 15(2) , 115-23, (1997)
Full Text: HTML
Abstract
SR 27417, a potent PAF receptor antagonist, inhibited in a dose-dependent manner the hypotensive effect of PAF in rats. It protected rats with an ED50 value of 6 +/- 2 micrograms/kg (n = 6), when given i.v., 1 min before PAF administration. After i.v. administration, SR 27417 exhibited extended duration of action, a significant protective effect was observed up to 48 h after the administration. After i.v. injection, SR 27417 (0.3, 1 and 3 mg/kg) afforded dose-dependent protection of actively sensitized rats against ovalbumin-induced hypotension but also totally reversed established antigen-induced hypotension. These results therefore confirm that PAF plays a major role in anaphylactic shock and suggest that SR 27417 may be an effective prophylactic as well as a potent curative drug in this pathology.
Related Compounds
Related Articles:
1995-07-01
[J. Lipid Mediat. Cell Signal. 12(1) , 49-57, (1995)]
1996-04-01
[Arzneimittelforschung 46(4) , 407-12, (1996)]
1994-09-27
[Proc. Natl. Acad. Sci. U. S. A. 91(20) , 9655-8, (1994)]
2002-04-01
[Am. J. Physiol. Gastrointest. Liver Physiol. 282(4) , G727-34, (2002)]
1997-05-30
[J. Chromatogr. A. 771(1-2) , 119-25, (1997)]